Unlocking the Potential of C12orf54: A Potential Drug Target and Biomarker for Chromosome 12 Open Reading Frame 54
![Review Report on C12orf54 Target / Biomarker](https://silexon.ai/img/target-biomarker-review.jpg?a=1)
![Content of Review Report on C12orf54 Target / Biomarker](https://silexon.ai/img/target-biomarker-review-content.jpg?a=2)
Unlocking the Potential of C12orf54: A Potential Drug Target and Biomarker for Chromosome 12 Open Reading Frame 54
Chromosome 12 (C12) is one of the human chromosomes responsible for the production of important proteins that play a crucial role in various cellular processes. Open reading frame (ORF) 54 (C12ORF54) is a gene located on chromosome 12 that has been identified as a potential drug target and biomarker. In this article, we will explore the biology of C12ORF54 and its potential as a drug target and biomarker.
Background
C12 is one of the chromosomes that are involved in the production of proteins that are essential for various cellular functions. ORFs are the regions of a chromosome that contain the instructions for the production of a protein. C12ORF54 is a gene located on chromosome 12 that has been identified as a potential drug target and biomarker.
C12ORF54 gene
C12ORF54 is a gene that is located on chromosome 12 at position 618.75 base pairs (bp) relative to the start of the gene. The ORF54 gene encodes a protein that is made up of 214 amino acids. The protein has a calculated molecular weight of 21.1 kDa and a predicted localization of 15.4% of the total protein mass within the ORF54 gene.
Function
The function of C12ORF54 is not well understood, but research has identified that it is involved in the production of a protein that is involved in the regulation of cellular processes. The protein is localized to the endoplasmic reticulum (ER) and has been shown to be involved in the regulation of protein stability and localization.
Drug Target Potential
C12ORF54 has been identified as a potential drug target due to its unique function and its location on chromosome 12. Studies have shown that the protein is involved in the regulation of protein stability and localization, which could make it an attractive target for small molecules that can modulate protein function. Additionally, the protein is also involved in the regulation of cellular processes, which could make it an attractive target for drugs that target cellular processes.
Biomarker Potential
C12ORF54 has also been identified as a potential biomarker for various diseases. The protein is involved in the regulation of protein stability and localization, which could make it an attractive target for diagnostic tools that can detect changes in protein function. Additionally, the protein is also involved in the regulation of cellular processes, which could make it an attractive target for drugs that target cellular processes.
Conclusion
In conclusion, C12ORF54 is a gene located on chromosome 12 that has been identified as a potential drug target and biomarker. The protein is involved in the production of a protein that is involved in the regulation of cellular processes, which makes it an attractive target for small molecules that can modulate protein function. Additionally, the protein is also involved in the regulation of protein stability and localization, which could make it an attractive target for diagnostic tools that can detect changes in protein function. Further research is needed to fully understand the function of C12ORF54 and its potential as a drug target and biomarker.
Protein Name: Chromosome 12 Open Reading Frame 54
The "C12orf54 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C12orf54 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
C12orf56 | C12orf57 | C12orf60 | C12orf74 | C12orf75 | C12orf76 | C13orf42 | C13orf46 | C14orf119 | C14orf132 | C14orf178 | C14orf180 | C14orf28 | C14orf39 | C14orf93 | C15orf32 | C15orf39 | C15orf40 | C15orf48 | C15orf61 | C15orf62 | C16orf46 | C16orf54 | C16orf74 | C16orf78 | C16orf82 | C16orf86 | C16orf87 | C16orf89 | C16orf90 | C16orf92 | C16orf95 | C16orf96 | C17orf100 | C17orf107 | C17orf49 | C17orf50 | C17orf58 | C17orf67 | C17orf75 | C17orf78 | C17orf80 | C17orf97 | C17orf98 | C17orf99 | C18orf21 | C18orf25 | C18orf32 | C18orf54 | C18orf63 | C19orf12 | C19orf18 | C19orf25 | C19orf33 | C19orf38 | C19orf44 | C19orf47 | C19orf48 | C19orf53 | C19orf67 | C19orf73 | C19orf81 | C19orf84 | C1D | C1GALT1 | C1GALT1C1 | C1GALT1C1L | C1orf100 | C1orf105 | C1orf109 | C1orf112 | C1orf115 | C1orf116 | C1orf122 | C1orf127 | C1orf131 | C1orf141 | C1orf146 | C1orf159 | C1orf162 | C1orf167 | C1orf185 | C1orf198 | C1orf21 | C1orf210 | C1orf216 | C1orf220 | C1orf226 | C1orf35 | C1orf43 | C1orf50 | C1orf52 | C1orf53 | C1orf54 | C1orf56 | C1orf68 | C1orf74 | C1orf87 | C1orf94 | C1QA